Effectiveness of Immune Checkpoint Inhibitor with Anti-PD-1 Monotherapy or in Combination with Ipilimumab in Younger versus Older Adults with Advanced Melanoma
Current Oncology · 2023
DOI: 10.3390/curroncol30100646 ↗Kurz gefasst
Fachartikel in der Zeitschrift Current Oncology, 2023. Verfasst von Taylor E Woo und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Division of Dermatology, University of Calgary, Calgary, AB T2N 1N4, Canada. Hauptthemen laut MEDLINE: Melanoma, Skin Neoplasms. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Gerontologische Pflege
Abstract (Originalsprache)
Background
The majority of melanoma is diagnosed in individuals between 55 and 84 years old. Current data varied in reporting differences in survival outcomes amongst different age groups.
Methods
A retrospective, multi-center, provincial cohort database was used to investigate the relationship between age (
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine, Division of Dermatology, University of Calgary, Calgary, AB T2N 1N4, Canada.
- Department of Oncology, Division of Medical Oncology, Tom Baker Cancer Centre, Calgary, AB T2N 4N2, Canada.
ORCID-Profile: Philip Q Ding, Siddhartha Goutam, Michael Sander, Benjamin Ewanchuk, Tina Cheng
Zitieren
APA
Woo, T. E., Stukalin, I., Ding, P. Q., Goutam, S., Sander, M., Ewanchuk, B., Cheung, W. Y., Heng, D. Y. C., & Cheng, T. (2023). Effectiveness of Immune Checkpoint Inhibitor with Anti-PD-1 Monotherapy or in Combination with Ipilimumab in Younger versus Older Adults with Advanced Melanoma. Current Oncology. https://doi.org/10.3390/curroncol30100646
Vancouver
Woo TE, Stukalin I, Ding PQ, Goutam S, Sander M, Ewanchuk B, et al. Effectiveness of Immune Checkpoint Inhibitor with Anti-PD-1 Monotherapy or in Combination with Ipilimumab in Younger versus Older Adults with Advanced Melanoma. Current Oncology. 2023. doi:10.3390/curroncol30100646
BibTeX
@article{Woo2023,
author = {Woo, Taylor E and Stukalin, Igor and Ding, Philip Q and Goutam, Siddhartha and Sander, Michael and Ewanchuk, Benjamin and Cheung, Winson Y and Heng, Daniel Y C and Cheng, Tina},
title = {Effectiveness of Immune Checkpoint Inhibitor with Anti-PD-1 Monotherapy or in Combination with Ipilimumab in Younger versus Older Adults with Advanced Melanoma},
journal = {Current Oncology},
year = {2023},
doi = {10.3390/curroncol30100646}
}
EUVIMED